Yang et al. [108] found that GRh2 directly binds with TOPK and directly inhibits TOPK activity in HCT-116; in a mechanistic study, they demonstrated that GRh2 inhibits the phosphorylation levels of ERK1/2 and H3 in colon cancer cells. This evidence concerns the gene MAPK3 and malignant colon neoplasm.